NEWS
Drug Protects Heart in Children Receiving Common Chemotherapy
The drug dexrazoxane, which can protect heart tissue from the oxidative damage caused by doxorubicin and other anthracycline drugs, significantly reduced the occurrence of long-term heart damage in children undergoing treatment for high-risk acute lymphoblastic leukemia (ALL). Importantly, dexrazoxane did not reduce the effectiveness of anthracycline chemotherapy. Read more > >
Mutations Linked to Two Uncommon Forms of Ovarian Cancer
Mutations may play key role in the early development of these cancersDeclines in U.S. Smoking Prevalence Stalled
Significant disparities according to income, education level persistMen with Low PSA Levels May Not Benefit from Further Prostate Cancer Screening
Longer follow-up is needed before recommendations can be madeHospitalization Near Death May Diminish Mental Health of Caregivers and Quality of Life for Cancer Patients
Caregivers suffer from post-traumatic stress disorder and prolonged grief disorder
A MESSAGE TO READERS
Don’t Forget the Bulletin Subscriber Survey!
If you subscribe to the NCI Cancer Bulletin and are familiar with our content, please take 10 minutes to complete our biannual subscriber survey. Your comments are important to help us improve this newsletter so it better meets your needs.
The survey is available through a separate e-mail to our subscribers; so, if you haven’t already subscribed to the Bulletin and want to participate in the survey, be sure to sign up. Our final reminder e-mail will be sent Wednesday, October 6. The survey will close October 12.
IN DEPTH
When Ovarian Cancer Returns Years Later
Reflecting on the 13 years between her cancers, advocate Susan Butler sees progress in treatment
XMRV Researchers Discuss the State of the Science
Workshop underscores the need to understand reasons for variation in research results
Featured Clinical Trial: Combining Vaccine and Antiandrogen Therapy for Prostate Cancer
Can the combination delay progression in men with castration-resistant, nonmetastatic disease?
Quitting Smoking? Find Support on Facebook
Smokefree Women launches video blog on the social networking site
UPDATES
Cancer.gov Update
- New Video Highlights a Daughter’s Experience Coping with Her Mother’s Cancer
- New Video Highlights a Daughter’s Experience Coping with Her Mother’s Cancer
FDA Update
- FDA Sends Warning Letters to Electronic Cigarette Companies
Notes
- Register for Cancer Control P.L.A.N.E.T. Cyber-seminars on Program Dissemination
- NIH Invites Comments on Draft Strategic Plan for Obesity Research
- Registration Open for 2010 NCI SBIR Investor Forum
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
